LRMR Larimar Therapeutics, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 4, 2026
$2,96
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$2,72minimo 52 sett.
$6,42massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$307M
P/E
-1.7
EPS
$-1.32
i tuoi badge
Intervallo 52 sett.
$3–$6
Rating Analisti
STRONG BUY
Prezzo Obiettivo
$14
P/E
-1.7
ROE
-167.4%
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
LRMR Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$2.96
Capitalizzazione di Mercato (MRQ)
$307M
P/E
-1.7
EPS
$-1.32
ROE
-167.4%
Intervallo 52 sett.
$3–$6
LRMR Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Informazioni su Larimar Therapeutics, Inc. - Common Stock Panoramica della società da Wikipedia
settoreHealthcare
industriaBiotechnology
dipendenti71
paeseUS
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi·2016-12-31 → 2019-12-31
EPS$-1.322020-12-31 → 2024-12-31
Flusso di cassa libero$-113M2016-12-31 → 2025-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | LRMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/E | -1.7media 5 anni ≈-3.4 | ≈-3.4 | · | · | |
| P/B (MRQ) | 2.4media 5 anni ≈2.5 | ≈2.5 | 1.9 | Sopravvalutato | |
| Price / FCF (Prezzo / FCF) | -2.2media 5 anni ≈-4.6 | ≈-4.6 | · | · | |
| Price / Cash Flow (Prezzo / Flusso di cassa) | -2.2media 5 anni ≈-4.7 | ≈-4.7 | · | · | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 3.1media 5 anni ≈2.5 | ≈2.5 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
| Metrica | Tendenza 5 anni | LRMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| ROA | -95.8%media 5 anni ≈-54.6% | ≈-54.6% | -47.5% | Debole | |
| ROE | -167.4%media 5 anni ≈-71.7% | ≈-71.7% | -90.1% | Debole | |
| ROIC | -220.9%media 5 anni ≈-87.2% | ≈-87.2% | -56.5% | Debole |
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | LRMR | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 4.7media 5 anni ≈7.8 | ≈7.8 | 5.2 | In linea | |
| Quick Ratio | 1.3media 5 anni ≈3.2 | ≈3.2 | 5.0 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-7.7%
Prossimo report
Nov 03, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 12, 2026 | $-0.30 | $-0.39 | 22.8% |
| 31 Marzo 2026 | Mag 14, 2026 | $-0.31 | $-0.55 | 43.2% |
| 31 Dicembre 2025 | $-0.73 | $-0.52 | -41.2% | |
| 30 Settembre 2025 | $-0.61 | $-0.41 | -48.0% | |
| 30 Giugno 2025 | $-0.41 | $-0.49 | 16.3% | |
| 31 Marzo 2025 | $-0.46 | $-0.43 | -7.8% | |
| 31 Dicembre 2024 | $-0.45 | $-0.32 | -39.1% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $154M | $73M | $28M | $24M | $38M | $31M | $21M | $48M | $41M | $40M | $55M | $27M | |
| SG&A Expense | $18M | $18M | $14M | $12M | $12M | $11M | $2M | $13M | $12M | $18M | $19M | $8M | |
| Operating Expenses | $172M | $91M | $42M | $37M | $50M | $43M | $23M | $61M | $53M | $58M | $74M | $36M | |
| Operating Income | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-23M | $-61M | $-53M | $-58M | $-74M | $-36M | |
| Interest Expense | · | · | · | · | · | · | $2M | $2M | $165.0K | $529.0K | $806.0K | $870.0K | |
| Interest Income | · | · | · | · | · | · | $2M | $2M | $996.0K | · | · | · | |
| Other Non-op | $7M | $10M | $5M | $1M | $-171.0K | $322.0K | $82.0K | $-246.0K | $971.0K | $347.0K | $-473.0K | $-946.0K | |
| Pretax Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| EPS (Basic) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| EPS (Diluted) | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · | |
| Shares (Basic) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| Shares (Diluted) | · | 61,256,084 | 43,901,241 | 25,761,394 | 17,164,284 | 11,883,155 | · | · | · | · | · | · | |
| EBITDA | $-172M | $-91M | $-42M | $-37M | $-50M | $-43M | $-46M | $-61M | $-53M | $-58M | · | $-36M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $85M | $33M | $27M | $27M | $70M | $68M | $1M | $49M | $41M | $32M | $36M | $58M | |
| Prepaid Expense | $5M | $12M | $3M | $2M | $2M | $5M | $4M | $2M | $2M | $1M | $2M | $1M | |
| Current Assets | $142M | $195M | $90M | $121M | $72M | $98M | $5M | $121M | $105M | $131M | $188M | $117M | |
| PP&E (Net) | $622.0K | $881.0K | $684.0K | $831.0K | $1M | $1M | $274.0K | $375.0K | $528.0K | $661.0K | $902.0K | $79.0K | |
| PP&E (Gross) | $3M | $2M | $2M | $2M | $2M | $1M | $453.0K | $925.0K | $1M | $981.0K | $1M | $129.0K | |
| Accum. Depreciation | $2M | $2M | $1M | $914.0K | $596.0K | $335.0K | $179.0K | $550.0K | $508.0K | $320.0K | $120.0K | $50.0K | |
| Other Non-current Assets | $523.0K | $596.0K | $659.0K | $638.0K | $669.0K | $419.0K | $90.0K | $57.0K | $57.0K | $61.0K | $94.0K | $242.0K | |
| Total Assets | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Accounts Payable | $5M | $2M | $1M | $2M | $2M | $3M | $4M | $4M | $3M | $3M | $7M | $2M | |
| Accrued Liabilities | $58M | $21M | $7M | $8M | $7M | $6M | $2M | $4M | $4M | $4M | $6M | $3M | |
| Short-term Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | $3M | $1M | |
| Current Liabilities | $65M | $24M | $10M | $11M | $9M | $9M | $6M | $13M | $7M | $10M | $17M | $7M | |
| Capital Leases | $3M | $4M | $5M | $5M | $5M | $6M | $6M | · | · | · | · | · | |
| Total Liabilities | $68M | $28M | $14M | $16M | $14M | $15M | $6M | $28M | $27M | $10M | $20M | $13M | |
| Long-term Debt | · | · | · | · | · | · | $15M | $20M | $20M | $3M | · | · | |
| Total Debt | · | · | · | · | · | · | $7M | $5M | · | $4M | · | $1M | |
| Common Stock | $83.0K | $64.0K | $43.0K | $43.0K | $18.0K | $15.0K | $6.0K | $37.0K | $27.0K | $27.0K | $27.0K | $23.0K | |
| Paid-in Capital | $513M | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-435M | $-269M | $-189M | $-152M | $-116M | $-66M | $-23M | $-351M | $-290M | $-238M | $-180M | $-105M | |
| AOCI | $54.0K | $148.0K | $81.0K | $-31.0K | · | $1.0K | $35.0K | $-33.0K | $-58.0K | $-80.0K | $-207.0K | $-35.0K | |
| Stockholders' Equity | $78M | $172M | $82M | $111M | $64M | $90M | $-694.0K | $3M | $78M | $122M | $169M | $104M | |
| Liabilities + Equity | $146M | $200M | $96M | $126M | $79M | $105M | $5M | $122M | $106M | $132M | $189M | $118M | |
| Shares Outstanding | 83,090,392 | 63,815,065 | 43,909,069 | 43,269,200 | 17,710,450 | 15,367,730 | 6,091,250 | 37,287,221 | 27,489,457 | 27,332,551 | 27,242,503 | 22,879,160 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $7M | $9M | $8M | $7M | $5M | $2M | $129.0K | $10M | $8M | $10M | $9M | $2M | |
| Restructuring | · | · | · | · | · | · | $6M | · | · | $1M | · | · | |
| Operating Cash Flow | $-113M | $-71M | $-33M | $-28M | $-42M | $-42M | $-23M | $-51M | $-44M | $-52M | $-60M | $-28M | |
| CapEx | $91.0K | $515.0K | $164.0K | $100.0K | $333.0K | $62.0K | $83.0K | $108.0K | $55.0K | $660.0K | $595.0K | $58.0K | |
| Investing Cash Flow | $100M | $-85M | $33M | $-91M | $24M | $17M | $-83.0K | $-7M | $36M | $51M | · | · | |
| Stock Issued | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | $130M | $103M | |
| Net Stock Activity | $65M | $162M | · | $75M | $20M | $76M | · | $65M | · | · | · | · | |
| Financing Cash Flow | $65M | $162M | $30.0K | $75M | $20M | $94M | $19M | $67M | $17M | $-3M | · | · | |
| Net Change in Cash | $52M | $6M | $-76.0K | $-43M | $2M | $68M | $-3M | $9M | $8M | $-3M | $-23M | $23M | |
| Free Cash Flow | $-113M | $-71M | $-34M | $-28M | $-42M | $-42M | $-42M | $-52M | $-44M | $-53M | · | $-28M | |
| Levered FCF | · | · | · | · | · | · | $-43M | $-53M | $-44M | $-53M | · | $-29M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -95.8% | -54.4% | -33.2% | -34.5% | -55.2% | -77.3% | -44.9% | -54.0% | -43.9% | -36.1% | · | -46.9% | |
| ROE | -167.4% | -43.5% | -42.4% | -30.8% | -74.2% | -44.2% | -163.6% | -62.2% | -52.0% | -39.8% | · | -203.4% | |
| ROIC | -220.9% | -52.9% | -51.1% | -32.9% | -78.3% | -47.7% | -75.0% | -61.9% | -67.8% | -46.5% | · | -33.6% |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 | 10.9 | 5.9 | 9.1 | 14.4 | 13.2 | · | 17.0 | |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 | 7.6 | 2.2 | 3.7 | 5.6 | 3.3 | · | 8.4 | |
| Debt / Equity | · | · | · | · | · | · | 0.1 | 0.1 | · | 0.0 | · | 0.0 | |
| Interest Coverage | · | · | · | · | · | · | -25.9 | -32.2 | -321.2 | -110.1 | · | -40.8 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.94 | $2.69 | $1.86 | $2.56 | $3.64 | $5.84 | $1.43 | $2.50 | $2.85 | $4.45 | · | $4.56 | |
| Cash Flow / Share | · | $-1.16 | $-0.76 | $-1.07 | $-2.45 | · | · | · | · | · | · | · | |
| Cash / Share | $1.03 | $0.52 | $0.61 | $0.62 | $3.96 | $4.43 | $0.73 | $1.32 | $1.48 | $1.18 | · | $2.54 | |
| EPS (TTM) | $-1.72 | $-1.32 | $-0.84 | $-1.37 | $-2.95 | $-3.57 | · | · | · | · | · | · |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-166M | $-81M | $-37M | $-35M | $-51M | $-42M | $-23M | $-61M | $-52M | $-58M | $-74M | $-36M | |
| Market Cap | $317M | $247M | $200M | $179M | $191M | $329M | $499M | $2.21B | $1.52B | $1.04B | · | $8.47B | |
| Enterprise Value | · | · | · | · | · | · | $479M | $2.17B | · | $1.01B | · | $8.41B | |
| P/E | -2.2 | -2.9 | -5.4 | -3.0 | -3.7 | -6.0 | · | · | · | · | · | · | |
| P/B | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | 9.3 | 23.7 | 19.5 | 8.6 | · | 81.1 | |
| P / Tangible Book | 4.1 | 1.4 | 2.4 | 1.6 | 3.0 | 3.7 | · | · | · | · | · | · | |
| P / Cash Flow | -2.8 | -3.5 | -6.0 | -6.5 | -4.5 | -7.8 | -12.2 | -43.0 | -34.8 | -20.1 | · | -299.8 | |
| P / FCF | -2.8 | -3.5 | -5.9 | -6.5 | -4.5 | -7.8 | -12.0 | -42.9 | -34.8 | -19.8 | · | -299.2 | |
| EV / EBITDA | · | · | · | · | · | · | -10.5 | -35.5 | · | -17.4 | · | -236.7 | |
| EV / FCF | · | · | · | · | · | · | -11.5 | -42.1 | · | -19.3 | · | -297.2 | |
| Earnings Yield | -45.1% | -34.1% | -18.5% | -33.2% | -27.3% | -16.7% | · | · | · | · | · | · |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $28M | $25M | $59M | $45M | $23M | $27M | $27M | $14M | $20M | $13M | $11M | $7M | $6M | $5M | $7M | $6M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $4M | $5M | $5M | $4M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | |
| Operating Expenses | $34M | $31M | $64M | $49M | $28M | $31M | $31M | $18M | $25M | $17M | $14M | $10M | $10M | $8M | $10M | $9M | |
| Operating Income | $-34M | $-31M | $-64M | $-49M | $-28M | $-31M | $-31M | $-18M | $-25M | $-17M | $-14M | $-10M | $-10M | $-8M | $-10M | $-9M | |
| Other Non-op | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $1M | $1M | $1M | $1M | $1M | $193.0K | |
| Income Tax | · | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-33M | $-30M | $-62M | $-48M | $-26M | $-29M | $-29M | $-15M | $-22M | $-15M | $-13M | $-9M | $-8M | $-7M | $-9M | $-8M | |
| EPS (Basic) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| EPS (Diluted) | · | · | · | $-0.61 | $-0.41 | $-0.46 | · | $-0.24 | $-0.34 | $-0.27 | $-0.29 | $-0.21 | $-0.19 | $-0.15 | $-0.04 | $-0.37 | |
| Shares (Basic) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| Shares (Diluted) | · | · | · | 78,324,767 | 64,027,892 | 63,964,008 | · | 63,806,158 | 63,801,792 | 53,553,707 | · | 43,903,738 | 43,897,603 | 43,897,603 | · | 22,228,228 | |
| EBITDA | $-34M | $-31M | · | $-49M | $-28M | $-31M | · | $-18M | $-25M | $-17M | · | $-10M | $-10M | $-8M | · | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $93M | $178M | $85M | $90M | $21M | $21M | $33M | $35M | $32M | $110M | $27M | $39M | $94M | $112M | $27M | $86M | |
| Prepaid Expense | $4M | $5M | $5M | $8M | $7M | $8M | $12M | $10M | $5M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Current Assets | $161M | $205M | $142M | $183M | $146M | $165M | $195M | $213M | $231M | $231M | $90M | $98M | $106M | $113M | $121M | $127M | |
| PP&E (Net) | $639.0K | $558.0K | $622.0K | $709.0K | $797.0K | $855.0K | $881.0K | $779.0K | $844.0K | $604.0K | $684.0K | $601.0K | $677.0K | $753.0K | $831.0K | $909.0K | |
| PP&E (Gross) | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $992.0K | $914.0K | $836.0K | |
| Other Non-current Assets | $480.0K | $504.0K | $523.0K | $542.0K | $561.0K | $582.0K | $596.0K | $621.0K | $636.0K | $678.0K | $659.0K | $634.0K | $644.0K | $632.0K | $638.0K | $643.0K | |
| Total Assets | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Accounts Payable | $8M | $9M | $5M | $11M | $4M | $2M | $2M | $2M | $3M | $2M | $1M | $756.0K | $2M | $695.0K | $2M | $849.0K | |
| Accrued Liabilities | $25M | $38M | $58M | $33M | $21M | $19M | $21M | $14M | $17M | $10M | $7M | $5M | $4M | $7M | $8M | $8M | |
| Current Liabilities | $34M | $48M | $65M | $45M | $27M | $22M | $24M | $16M | $21M | $13M | $10M | $7M | $7M | $8M | $11M | $9M | |
| Capital Leases | $4M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | |
| Total Liabilities | $38M | $50M | $68M | $48M | $30M | $26M | $28M | $21M | $26M | $17M | $14M | $11M | $12M | $13M | $16M | $14M | |
| Common Stock | $103.0K | $103.0K | $83.0K | $86.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $64.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | $43.0K | |
| Paid-in Capital | $625M | $622M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-497M | $-464M | $-435M | $-372M | $-325M | $-298M | $-269M | $-240M | $-225M | $-203M | $-189M | $-176M | $-166M | $-158M | $-152M | $-142M | |
| AOCI | $-12.0K | $6.0K | $54.0K | $66.0K | $-9.0K | $54.0K | $148.0K | $358.0K | $-150.0K | $-25.0K | $81.0K | $7.0K | $12.0K | · | $-31.0K | $-40.0K | |
| Stockholders' Equity | $127M | $158M | $78M | $139M | $120M | $144M | $172M | $198M | $211M | $231M | $82M | $93M | $100M | $106M | $111M | $119M | |
| Liabilities + Equity | $165M | $209M | $146M | $187M | $150M | $170M | $200M | $219M | $237M | $248M | $96M | $104M | $112M | $119M | $126M | $133M | |
| Shares Outstanding | 103,882,937 | 103,882,937 | 83,090,392 | 85,590,392 | 64,027,892 | 64,027,892 | 63,815,065 | 63,806,628 | 63,802,517 | 63,800,017 | 43,909,069 | 43,905,903 | 43,269,200 | 43,269,200 | 43,269,200 | 43,269,200 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-44M | $-45M | · | · | $-19M | $-27M | $-22M | $-25M | $-14M | $-10M | $-9M | $-9M | $-7M | $-8M | $-7M | $-6M | |
| CapEx | · | · | $0 | $23.0K | $19.0K | $49.0K | $179.0K | $62.0K | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $-41M | $29M | · | · | $19M | $14M | $19M | $27M | $-63M | $-68M | $-3M | $-46M | $-10M | $92M | $-52M | $-3M | |
| Stock Issued | · | · | $-201.0K | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-435.0K | $108M | · | · | · | · | $36.0K | $30.0K | $-334.0K | $162M | $0 | · | · | · | $-316.0K | · | |
| Net Change in Cash | $-85M | $93M | $-5M | $70M | $-539.0K | $-12M | $-3M | $3M | $-78M | $83M | $-12M | $-56M | $-17M | $85M | $-59M | $66M | |
| Free Cash Flow | · | · | · | · | · | $-27M | · | · | · | · | · | · | · | · | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -20.8% | -15.6% | · | -23.5% | -13.5% | -14.0% | · | -9.6% | -12.4% | -8.0% | · | -7.6% | -9.6% | -6.9% | · | -7.5% | |
| ROE | -26.5% | -19.6% | · | -28.3% | -15.8% | -15.6% | · | -10.7% | -13.9% | -8.7% | · | -8.6% | -11.2% | -8.0% | · | -8.7% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.7 | 4.3 | · | 4.1 | 5.5 | 7.5 | · | 13.1 | 10.9 | 18.0 | · | 15.0 | 14.6 | 14.2 | · | 13.5 | |
| Quick Ratio | 2.7 | 3.7 | · | 2.0 | 0.8 | 1.0 | · | 2.2 | 1.5 | 8.6 | · | 5.9 | 13.0 | 13.9 | · | 9.1 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.23 | $1.52 | · | $1.62 | $1.87 | $2.25 | · | $3.11 | $3.31 | $3.62 | · | $2.11 | $2.31 | $2.46 | · | $2.74 | |
| Cash Flow / Share | · | · | · | · | · | $-0.41 | · | · | · | $-0.19 | · | · | · | $-0.17 | · | · | |
| Cash / Share | $0.89 | $1.71 | · | $1.05 | $0.32 | $0.33 | · | $0.55 | $0.51 | $1.73 | · | $0.88 | $2.18 | $2.58 | · | $1.99 | |
| EPS (TTM) | · | · | · | · | · | · | · | $-1.14 | $-1.11 | $-0.96 | · | $-0.59 | $-0.75 | $-1.03 | · | $-1.81 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-173M | $-166M | · | $-132M | $-100M | $-95M | · | $-65M | $-58M | $-45M | · | $-33M | $-33M | $-33M | · | $-35M | |
| Market Cap | $317M | $467M | · | $276M | $185M | $138M | · | $418M | $463M | $484M | · | $173M | $135M | $196M | · | $138M | |
| P/E | · | · | · | · | · | · | · | -5.7 | -6.5 | -7.9 | · | -6.7 | -4.2 | -4.4 | · | -1.8 | |
| P/B | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Tangible Book | 2.5 | 3.0 | · | 2.0 | 1.5 | 1.0 | · | 2.1 | 2.2 | 2.1 | · | 1.9 | 1.4 | 1.8 | · | 1.2 | |
| P / Cash Flow | · | -10.5 | · | · | · | -5.2 | · | · | · | -46.5 | · | · | · | -26.0 | · | · | |
| Earnings Yield | · | · | · | · | · | · | · | -17.4% | -15.3% | -12.7% | · | -14.9% | -24.0% | -22.7% | · | -56.6% |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utile netto | $-166M | $-81M | $-37M | $-35M | $-51M |
| EPS Diluito | · | $-1.32 | $-0.84 | $-1.37 | $-2.95 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | 2.2 | 8.0 | 9.5 | 11.3 | 8.2 |
| Quick Ratio | 1.3 | 1.4 | 2.8 | 2.5 | 7.9 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-113M | $-71M | $-34M | $-28M | $-42M |
Proprietari istituzionali (13F) 178 filer · $309.2M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
178
Valore detenuto
$309.2M
Nuove posizioni
31
Posizioni chiuse
29
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 31 (-21 vs trimestre precedente) | 29 (+15 vs trimestre precedente) | 70 (+12 vs trimestre precedente) | 44 (+3 vs trimestre precedente) | +7.7M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. | $108.601.271 | 35.606.974 | 35,13% | Azioni |
| Blue Owl Capital Holdings LP | $27.947.629 | 9.163.157 | 9,04% | Azioni |
| BlackRock, Inc. | $17.318.006 | 5.678.035 | 5,60% | Azioni |
| VANGUARD GROUP INC | $11.606.083 | 3.046.216 | 3,75% | Azioni |
| Defilade Capital Management, L.P. | $11.193.912 | 3.670.135 | 3,62% | Azioni |
| Driehaus Capital Management LLC | $9.648.440 | 3.163.423 | 3,12% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $9.073.448 | 2.974.901 | 2,93% | Azioni |
| RTW INVESTMENTS, LP | $7.826.297 | 2.565.999 | 2,53% | Azioni |
| AQR CAPITAL MANAGEMENT LLC | $7.232.813 | 2.371.414 | 2,34% | Azioni |
| MARSHALL WACE, LLP | $6.137.996 | 2.012.458 | 1,99% | Azioni |
| DAFNA Capital Management LLC | $6.124.900 | 2.008.164 | 1,98% | Azioni |
| GOLDMAN SACHS GROUP INC | $5.346.375 | 1.752.910 | 1,73% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $5.121.921 | 1.679.003 | 1,66% | Azioni |
| Qube Research & Technologies Ltd | $5.005.178 | 1.641.042 | 1,62% | Azioni |
| CITADEL ADVISORS LLC | $4.443.316 | 1.456.825 | 1,44% | Azioni |
| STATE STREET CORP | $4.306.002 | 1.411.804 | 1,39% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $4.279.675 | 1.403.172 | 1,38% | Azioni |
| Woodline Partners LP | $4.272.593 | 1.400.850 | 1,38% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $4.065.763 | 1.333.037 | 1,32% | Azioni |
| DIMENSIONAL FUND ADVISORS LP | $2.932.299 | 961.083 | 0,95% | Azioni |
| FMR LLC | $2.858.971 | 937.368 | 0,92% | Azioni |
| SPHERA FUNDS MANAGEMENT LTD. | $2.824.312 | 926.004 | 0,91% | Azioni |
| Nuveen, LLC | $2.730.677 | 895.304 | 0,88% | Azioni |
| Alyeska Investment Group, L.P. | $1.882.494 | 617.211 | 0,61% | Azioni |
| NORTHERN TRUST CORP | $1.678.311 | 550.266 | 0,54% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.580.815 | 518.300 | 0,51% | Opzione Put |
| VANGUARD FIDUCIARY TRUST CO | $1.366.912 | 448.168 | 0,44% | Azioni |
| Fi3 FINANCIAL ADVISORS, LLC | $1.263.896 | 2.915 | 0,41% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $1.218.604 | 399.542 | 0,39% | Azioni |
| SummitTX Capital, L.P. | $1.074.466 | 352.284 | 0,35% | Azioni |
| JPMORGAN CHASE & CO | $1.049.648 | 328.015 | 0,34% | Azioni |
| Gem Investment Advisors, LLC | $974.533 | 319.519 | 0,32% | Azioni |
| Burkehill Global Management, LP | $915.000 | 300.000 | 0,30% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $907.201 | 297.443 | 0,29% | Azioni |
| HAP Trading, LLC | $848.766 | 262.776 | 0,27% | Azioni |
| ADAR1 Capital Management, LLC | $831.872 | 272.745 | 0,27% | Azioni |
| Cerity Partners LLC | $828.326 | 271.582 | 0,27% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $821.975 | 269.500 | 0,27% | Opzione Call |
| CITADEL ADVISORS LLC | $732.610 | 240.200 | 0,24% | Opzione Put |
| TWO SIGMA INVESTMENTS, LP | $720.206 | 236.133 | 0,23% | Azioni |
| Seven Fleet Capital Management LP | $704.309 | 230.921 | 0,23% | Azioni |
| HAP Trading, LLC | $687.173 | 237.776 | 0,22% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $631.255 | 206.969 | 0,20% | Azioni |
| IEQ CAPITAL, LLC | $620.258 | 203.363 | 0,20% | Azioni |
| Caption Management, LLC | $588.705 | 193.018 | 0,19% | Azioni |
| Soleus Capital Management, L.P. | $573.711 | 188.102 | 0,19% | Azioni |
| Cubist Systematic Strategies, LLC | $523.775 | 162.159 | 0,17% | Azioni |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $520.254 | 170.575 | 0,17% | Azioni |
| Susquehanna Portfolio Strategies, LLC | $503.726 | 165.156 | 0,16% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $486.990 | 108.220 | 0,16% | Azioni |
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P., Deerfield Healthcare Innovations Fund, L.P., Deerfield Private Design Fund IV, L.P., Deerfield Partners, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt, L.P., Deerfield Management Company, L.P., James E. Flynn ×12 depositi | 02 Marzo 2026 | 34,41% | Modifica | Investimento passivo | SEC |
| Chondrial Therapeutics Holdings, LLC ×2 depositi | 30 Giugno 2020 | · | Deposito iniziale | · | SEC |
| Chondrial Therapeutics, Inc. | 27 Dicembre 2019 | · | Deposito iniziale | M&A / vendita | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 29 insider · 13 dirigenti · 18 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Carole Ben-Maimon | President and CEO | 26 Gennaio 2026 A | 368.276 | 0 | 0 | $0 |
| Jeffrey S. Hatfield | Chief Executive Officer | 22 Gennaio 2019 A | · | 0 | 0 | $0 |
| Michael Celano | Chief Financial Officer | 26 Gennaio 2026 A | 215.785 | 0 | 0 | $0 |
| Patricia L Allen | Chief Financial Officer | 22 Gennaio 2019 A | 19.793 | 0 | 0 | $0 |
| John B. Harlow Jr. | President and COO | 29 Settembre 2026 A | 50.000 | 0 | 0 | $0 |
| Thomas E. Hughes | President and Chief Scientific Officer | 28 Giugno 2018 S | 125.247 | 0 | 0 | $0 |
| Patrick Loustau | President | 31 Marzo 2016 A | · | 0 | 0 | $0 |
| Gopi Shankar | Chief Development Officer | 26 Gennaio 2026 A | 76.443 | 0 | 0 | $0 |
| Russell Clayton | Chief Medical Officer | 26 Gennaio 2026 A | 71.443 | 0 | 0 | $0 |
| Singhal Priya | Head of Research & Development | 02 Aprile 2019 A | · | 0 | 0 | $0 |
| Brian Mcveigh | Chief Business Officer | 22 Gennaio 2019 A | · | 0 | 0 | $0 |
| Dennis D Kim | Chief Medical Officer | 22 Gennaio 2019 A | 21.443 | 0 | 0 | $0 |
| Alicia Secor | Chief Commercial Officer | 31 Marzo 2016 A | 0 | 0 | 0 | $0 |
| Thomas Edward Hamilton | Direttore | 06 Luglio 2026 P | 714.798 | 2 | 0 | $667.000 |
| Joseph Truitt | Direttore | 19 Maggio 2026 A | 2.750 | 0 | 0 | $0 |
| Frank E Thomas | Direttore | 19 Maggio 2026 A | 7.000 | 1 | 0 | $25.000 |
| Jeffrey W Sherman | Direttore | 19 Maggio 2026 A | 5.000 | 1 | 0 | $25.000 |
| Jonathan S Leff | Direttore | 19 Maggio 2026 A | · | 0 | 0 | $0 |
| Peter Barrett | Direttore | 10 Maggio 2022 A | 4.643.327 | 0 | 0 | $0 |
| Thomas O Daniel | Direttore | 12 Maggio 2021 A | 19.452 | 0 | 0 | $0 |
| Wendy Everett | Direttore | 26 Giugno 2019 A | · | 0 | 0 | $0 |
| Cameron Geoffrey Mcdonough | Direttore | 26 Giugno 2019 A | 0 | 0 | 0 | $0 |
| Robert J Perez | Direttore | 26 Giugno 2019 A | 5.322 | 0 | 0 | $0 |
| John L Lamattina | Direttore | 26 Giugno 2019 A | 31.376 | 0 | 0 | $0 |
| Bruce Booth | Direttore | 03 Gennaio 2018 A | 4.638.028 | 0 | 0 | $0 |
| Frances K Heller | Direttore | 13 Ottobre 2017 P | 47.961 | 0 | 0 | $0 |
| Kevin P Starr | Direttore | 24 Settembre 2015 J | 370.323 | 0 | 0 | $0 |
| Avi Y. Goldberg | Direttore | 18 Settembre 2015 S | 53.734 | 0 | 0 | $0 |
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC | Proprietario del 10% | 26 Giugno 2020 J | 8 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduti da 21 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| IBRN · iShares Trust | 0,21% | 4.010 SH | 11 Settembre 2026 | Giornaliero |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,11% | 92.953 SH | 01 Ottobre 2026 | Giornaliero |
| IWC · iShares Trust | 0,06% | 225.822 SH | 11 Settembre 2026 | Giornaliero |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 7.348 SH | 01 Ottobre 2026 | Giornaliero |
| IWO · iShares Trust | 0,02% | 625.151 SH | 11 Settembre 2026 | Giornaliero |
| IBB · iShares Trust | 0,01% | 394.961 SH | 11 Settembre 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 382.844 SH | 19 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 71.780 SH | 19 Agosto 2026 | Giornaliero |
| DFAS · Dimensional ETF Trust | 0,01% | 340.789 NS | 31 Luglio 2026 | N-PORT |
| IWM · iShares Trust | 0,01% | 1.693.182 SH | 11 Settembre 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 31.780 NS | 31 Luglio 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4.394 NS | 31 Luglio 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 12.923 NS | 31 Luglio 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 11.721 NS | 31 Luglio 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 105.245 NS | 31 Luglio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 17.386 SH | 10 Settembre 2026 | Giornaliero |
| DFAU · Dimensional ETF Trust | 0,00% | 11.156 NS | 31 Luglio 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 699.471 SH | 19 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.206.446 SH | 19 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.400 SH | 19 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 172.125 SH | 19 Agosto 2026 | Giornaliero |
LRMR Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 17 analisti
COMPRA
Target mediano
$13.00
+339,2%
8 47,1%
Acquisto forte
8 47,1%
Compra
1 5,9%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
10 analisti · 2026-09-29Target medio $14.40 +386,5%
← Sotto tutti i target
Prezzo attuale $2.96
Basso$5.00
Media$14.40
Alto$26.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| LRMR | $317M | -2.2 | · | · | -167.4% | · |
| BBOT | $1.00B | -2.9 | · | · | -146.2% | · |
| BNTC | $460M | -13.7 | · | · | -25.0% | · |
| SCTX | · | · | · | · | · | · |
| CABA | $220M | -1.0 | · | · | -115.5% | · |
| PRLD | · | -2.2 | 73.4% | -819.6% | -137.7% | · |
| LXEO | $725M | -5.3 | · | · | -51.9% | · |
| ABEO | $290M | 5.2 | 147.5% | 1223.1% | 44.1% | · |
| VNDA | $521M | -2.4 | 8.7% | -102.0% | -54.2% | · |
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 4, 2026